(1R,9S)-(-)-β-Hydrastine - CAS 118-08-1
Not Intended for Therapeutic Use. For research use only.
Product Name:
Catalog Number:
(1R,9S)-(-)-beta-Hydrastine;Hydrastine base
CAS Number:
Hydrastine, a natural alkaloid compound, could be used as a dopamine biosynthesis inhibitor.
Molecular Weight:
Molecular Formula:
Canonical SMILES:
Chemical Structure
CAS 118-08-1 (1R,9S)-(-)-β-Hydrastine

Related Products

(CAS: 1000998-62-8)

BMS711939 is a selective and potent peroxisome proliferator-activated receptor α(PPARα) agonist with EC50 value of 4 nM for human PPARα. It is >1000-fold select...

CAS 1257-08-5 (-)-Epicatechin gallate

(-)-Epicatechin gallate
(CAS: 1257-08-5)

(−)-Epicatechin gallate (ECG) is a natural catechin with a single galloyl group. Like EGCG, it inhibits the growth of cancer cells and has anti-inflammatory eff...

CAS 54706-99-9 20-Deoxyingenol

(CAS: 54706-99-9)

20-Deoxyingenol is a diterpene derivative of Ingenol, isolated from the seeds of Euphorbia lathyris L., which has anti-tumor activity when used topically for th...

CAS 27741-01-1 Geniposidic acid

Geniposidic acid
(CAS: 27741-01-1)

Geniposidic acid is a natural chemical compound, classified as an iridoid glucoside, found in a variety of plants including Eucommia ulmoides and Gardenia jasmi...

CAS 1156-19-0 Tolazamide

(CAS: 1156-19-0)

Tolazamide, a sulphonylurea derivative, could be a hypoglycemic agent which is commonly used in Type 2 diabetes.

CAS 67920-52-9 Sodium Danshensu

Sodium Danshensu
(CAS: 67920-52-9)

Sodium Danshensu is a mono sodium of danshensu, which is a natural phenolic acid of caffeic acid derivatives isolated from Salvia miltiorrhiza.

CAS 4204-99-3 MK190

(CAS: 4204-99-3)

MK190 is a synthetic bio-active chemical.

CAS 135202-79-8 Ilonidap

(CAS: 135202-79-8)

Ilonidap is an anti-Inflammatory agent. No detailed information has been published yet.

CAS 50-70-4 Sorbitol

(CAS: 50-70-4)

Sorbitol is a sugar alcohol and a sugar substitute.

Glutaminase C-IN-1
(CAS: 311795-38-7)

Glutaminase C-IN-1, with effect to suppresse breast cancer cell growth and invasive activity in vitro, it is an allosteric, cell-permeable and reversible inhibi...

CAS 24584-09-6 Dexrazoxane

(CAS: 24584-09-6)

Dexrazoxane is a cardioprotective compound against anthracyclines. It is highly protective in reducing anthracycline-induced cardiotoxicity and extravasation in...

CAS 105956-99-8 Clinafloxacin hydrochloride

Clinafloxacin hydrochloride
(CAS: 105956-99-8)

Clinafloxacin hydrochloride is a novel fluoroquinolone antimicrobial agent as a potent intraphagocytic bactericidal agent. It displays broad-spectrum antibacter...

CAS 79551-86-3 20-Hydroxy-(5Z,8Z,11Z,14Z)-eicosatetraenoic acid

(CAS: 79551-86-3)

20-Hydroxy-(5Z,8Z,11Z,14Z)-eicosatetraenoic acid is a potent vasoconstrictor produced in vascular smooth muscle cells. Its EC50 value is < 10 nM. It is a cytoch...

(CAS: 165682-93-9)

O4I2 is a potent inducers of Oct3/4. O4I2 showed high activity in enforcing Oct3/4 expression. O4I2 is a new class of small molecules suitable for iPSC generati...

CAS 134418-28-3 Dehydroandrographolide

(CAS: 134418-28-3)

Dehydroandrographolide is a natural diterpenoid found in Andrographis paniculata. It possesses activity against hepatitis B virus DNA replication.

CAS 115-67-3 paramethadione

(CAS: 115-67-3)

This active molecular is an an antiepileptic and anticonvulsant agent. It is associated with fetal trimethadione syndrome that is also called as paramethadione ...

CAS 585531-74-4 BFCAs-1

(CAS: 585531-74-4)

BFCAs-1 is a polyamino polycarboxylic bifunctional chelating agent, which has a broad range of applications in chemistry, biology and medicine and diagnostic im...

CAS 1214-39-7 6-Benzylaminopurine

(CAS: 1214-39-7)

6-Benzylaminopurine, a purine-based first-generation synthetic cytokinin, could stimulate plant growth.

(CAS: 178946-89-9)

C-DIM12 is a novel synthetic activator of Nurr1. C-DIM12 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro. .

CAS 938-73-8 2-Ethoxybenzamide

(CAS: 938-73-8)

2-Ethoxybenzamide is a common analgesic and anti-inflammatory drug. It is used to reduce the fever, headaches, and other minor aches and pains. It is an ingredi...

Reference Reading

1.Enantio-selective inhibition of (1R,9S)- and (1S,9R)-beta-hydrastines on dopamine biosynthesis in PC12 cells.
Yin SY1, Kim YM, Lee JJ, Jin CM, Yang YJ, Ma JJ, Kang MH, Kai M, Lee MK. Neuropharmacology. 2004 Dec;47(7):1045-52.
The inhibitory effects of (1R,9S)- and (1S,9R)-enantiomers of beta-hydrastine (BHS) on dopamine biosynthesis in PC12 cells were investigated. (1R,9S)-BHS decreased the intracellular dopamine content with the IC50 value of 14.3 microM at 24 h, but (1S,9R)-BHS did not. (1R,9S)-BHS was not cytotoxic at concentrations up to 250 microM towards PC12 cells. In these conditions, (1R,9S)-BHS inhibited tyrosine hydroxylase (TH) activity mainly in a concentration-dependent manner (33% inhibition at 20 microM) and decreased TH mRNA level in PC12 cells. The inhibitory patterns of dopamine content and TH activity by (1R,9S)-BHS showed similar behavioral curves. (1R,9S)-BHS at 10-50 microM also reduced the intracellular cyclic AMP level and Ca2+ concentration. In addition, treatment of L-DOPA at 20-50 microM for 24 h increased the intracellular dopamine content to 198-251% compared with the control in PC12 cells. However, the increase in dopamine levels induced by L-DOPA (20-50 microM) was reduced when L-DOPA was combined with (1R,9S)-BHS (10-50 microM).
2.Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells.
Kim SH1, Shin JS, Lee JJ, Yin SY, Kai M, Lee MK. Planta Med. 2001 Oct;67(7):609-13.
The effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells were investigated. Treatments of PC12 cells with (1R,9S)-beta-hydrastine hydrochloride [(+)-beta-hydrastine HCl] and (1R,9S)-beta-hydrastine [(-)-beta-hydrastine] showed 50.6 % and 33.1 % inhibition of dopamine content at a concentration of 10 microM for 48 h. However, (1S,9R)-beta-hydrastine [(+)-beta-hydrastine] and hydrastinine hydrochloride did not reduce dopamine content. The IC(50) values of (1R,9S)-beta-hydrastine hydrochloride and (1R,9S)-beta-hydrastine were 9.3 microM and 20.7 microM , respectively. Next, the intracellular mechanisms of (1R,9S)-beta-hydrastine hydrochloride in PC12 cells were investigated. Dopamine content decreased at 6 h and reached a minimal level at 24 h after the exposure of PC12 cells to 20 microM (1R,9S)-beta-hydrastine hydrochloride. Tyrosine hydroxylase (TH) activity was inhibited at 6 h following the treatment with (1R,9S)-beta-hydrastine hydrochloride, and was maintained at a reduced level for up to 36 h in PC12 cells (17 - 27 % inhibition at 20 microM), whereas TH mRNA level was not found to alter for 24 h.
3.Effects of (1R,9S)-beta-hydrastine on l-DOPA-induced cytotoxicity in PC12 cells.
Yin SY1, Lee JJ, Kim YM, Jin CM, Yang YJ, Kang MH, Kai M, Lee MK. Eur J Pharmacol. 2004 Mar 19;488(1-3):71-7.
(1R,9S)-beta-Hydrastine in lower concentrations of 10-50 microM inhibits dopamine biosynthesis in PC12 cells. In this study, the effects of (1R,9S)-beta-hydrastine on L-DOPA (L-3,4-dihydroxyphenylalanine)-induced cytotoxicity in PC12 cells were investigated. (1R,9S)-Hydrastine at concentrations up to 250 microM did not reduce cell viability. However, at concentrations higher than 500 microM it caused cytotoxicity in PC12 cells, as determined with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, TUNEL (terminal deoxynucleotidyltransferase dUTP nick-end labeling) method and flow cytometry. Exposure of PC12 cells to cytotoxic concentrations of (1R,9S)-beta-hydrastine (500 and 750 microM) in combination with L-DOPA (20, 50 and 100 microM) after 24 or 48 h resulted in a significant decrease in cell viability compared with the effects of (1R,9S)-beta-hydrastine or L-DOPA alone, and apoptotic cell death was observed.
4.Effects of (1R,9S)-beta-hydrastine on intracellular calcium concentration in PC12 ce
Yin SY1, Kim YM, Lee JJ, Jin CM, Yang YJ, Park SK, Yoo SK, Lee MK. Biol Pharm Bull. 2007 Aug;30(8):1547-50.
(1R,9S)-beta-hydrastine (BHS) decreases the basal intracellular Ca(2+) concentration ([Ca(2+)](i)) in PC12 cells.(5) This study examined the effects of (1R,9S)-BHS on [Ca(2+)](i) in PC12 cells. (1R,9S)-BHS at 10-100 microM in combination with a high extracellular K+ level (56 mM) inhibited the release of dopamine in a concentration-dependent manner with an IC(50) value of 66.5 microM. BHS at 100 microM inhibited the sustained increase in [Ca(2+)](i) induced by a high K+ level (56 mM), and had an inhibitory effect on the 2 microM nifedipine-induced blockage of the K+ -stimulated sustained increase in [Ca(2+)](i). In addition, (1R,9S)-BHS at 100 microM prevented the rapid and sustained increase in [Ca(2+)](i) elicited by 20 mM caffeine, but did not have an effect on the increase induced by 1 microM thapsigargin, in the presence of external Ca(2+). These results suggest that the active sites of (1R,9S)-BHS are mainly L-type Ca(2+) channels and caffeine-sensitive Ca(2+)-permeable channels in PC12 cells.